Effects of infestation by cowpea aphid (Homoptera: Aphididae) on different growth stages of resistant and susceptible cowpea cultivars

Field studies were conducted to characterise the effects of infestations by adult and nymphal stages of cowpea aphid, Aphis craccivora Koch, on the growth and yield of cowpea, Vigna unguiculata (L.) Walp. Seedling, flowering, and podding stage plants of aphid-resistant (cv. ICV-12) and aphid-susceptible (cv. ICV-1) cowpea cultivars were used in the studies. Four treatments (consisting of infestations with adult and nymphal aphids, caged controls and uncaged controls) were administered on plants for 22 days post-treatment. Eight parameters of crop success were measured: extended leaf heights (ELH); plant mortality; incidence of sooty mould; incidence and abundance of natural enemy species; crop growth parameters (net assimilation rate, [NAR] in g/ dm2/day, and crop growth rate [CGR] in g/dm2 land surface/day); and plant yields (seeds per pod, weight per seed). Data were analysed using analysis of variance (ANOVA), orthogonal contrasts and 95% confidence intervals (C.I.). There were no significant (P > 0.05) differences between adult and nymphal infestations or between caged and uncaged controls, so the respective sets of data were combined for comparisons of aphid infestations with control treatments. Infestations caused severe plant stunting and other growth deformities, drastic yield reductions, higher plant mortality, greater incidence of natural enemies and abundance of Cheilomenes spp. on cv. ICV-1 than on cv. ICV-12, and on infested and uninfested plants. Aphid infestations did not significantly affect the incidence of sooty mould on plants of cv. ICV-12 or cv. ICV-

Extracorporeal membrane oxygenation (ECMO): extended indications for artificial support of both heart and lungs

Extracorporeal membrane oxygenation (ECMO) was used to achieve temporary artificial support in cardiac and pulmonary function in 22 patients from 1987 to September 1990. Standard indications were postcardiotomy cardiogenic shock (n = 4), neonatal (n = 1) and adult respiratory distress syndrome (n = 4). ECMO was also used for extended indications, such as graft failure following heart (n = 11) or lung transplantation (n = 2). In six of these cases ECMO was instituted as a bridge device to subsequent retransplantation of either the heart (n = 4) or one lung (n = 2). One out of nine patients supported by ECMO for standard indications, and two out of 13 patients supported for extended indications are long-term survivors. This series illustrates the results with ECMO in emergency situations, in patients under immunosuppressive protocols, or in patients with advanced lung failure requiring almost complete artificial gas exchange. In such complex situations, ECMO does provide stabilization until additional therapeutic measures are in effect. ECMO cannot be recommended for postoperative cardiogenic shock but short-term ECMO support is an accepted method in most cases with graft failure or pulmonary failure or other origin

Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts?

Positron emission tomography, cardiovascular magnetic resonance and multislice computed tomography have contributed to changing our pathophysiological understanding of many conditions. Clinically, they have provided new tools for the identification of preclinical disease and a better understanding of how disease progresses. The application of these imaging modalities to preclinical disease and the use of these techniques in patients with overt cardiovascular disease are reviewed